Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 15, 2019

SELL
$22.67 - $35.0 $2,062 - $3,185
-91 Closed
0 $0
Q4 2018

Jan 11, 2019

SELL
$27.23 - $45.56 $8,577 - $14,351
-315 Reduced 77.59%
91 $3,000
Q3 2018

Oct 16, 2018

BUY
$37.57 - $50.34 $15,253 - $20,438
406 New
406 $18,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.